An intranasally administered IgM protects against antigenically distinct subtypes of influenza A viruses

Abstract Engineering broadly neutralizing monoclonal antibodies (mAbs) targeting the hemagglutinin (HA) of Influenza A virus (IAV) is a promising approach for intervention of seasonal flu. However, HA plasticity often leads to resistant strains that compromise mAb potency as bivalent IgGs. Here we h...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Ashwin Kumar Ramesh, Jwala Priyadarsini Sivaccumar, Xiaohua Ye, Luona Yang, Hailong Guo, Chen-Ni Chin, Sha Ha, John W. Shiver, William R. Strohl, Yan Xu, Haijuan Du, Tongqing Zhou, Ningyan Zhang, Kai Xu, Xinli Liu, Tong-Ming Fu, Zhiqiang An
Format:	Artigo
Jezik:	Inglês
Izdano:	Nature Portfolio 2025-04-01
Serija:	Nature Communications
Online dostop:	https://doi.org/10.1038/s41467-025-59294-0
Oznake:	Označite Brez oznak, prvi označite!